XML 18 R7.htm IDEA: XBRL DOCUMENT v3.24.2
CONDENSED CONSOLIDATED STATEMENTS OF STOCKHOLDERS' EQUITY - USD ($)
$ in Thousands
Total
Common Stock
Additional Paid-In Capital
Retained Earnings
Accumulated Other Comprehensive Income (Lossses)
Treasury Stock
Balance at beginning of period (in shares) at Dec. 31, 2022   47,675,796        
Balance at beginning of period at Dec. 31, 2022 $ 397,613 $ 766 $ 665,941 $ 188,241 $ (882) $ (456,453)
Increase (Decrease) in Stockholders' Equity [Roll Forward]            
Net income 51,213     51,213    
Foreign currency translation 564       564  
Stock-based compensation (in shares)   480,463        
Stock-based compensation 2,766 $ 8 2,758      
Stock repurchase (in shares)   (540,875)        
Stock repurchase (23,566)         (23,566)
Common stock dividends (4,055)     (4,055)    
Unrealized loss on derivative instruments (236)       (236)  
Stock option exercises (in shares)   10,683        
Stock option exercises 144   144      
Balance at end of period (in shares) at Mar. 31, 2023   47,626,067        
Balance at end of period at Mar. 31, 2023 424,443 $ 774 668,843 235,399 (554) (480,019)
Balance at beginning of period (in shares) at Dec. 31, 2022   47,675,796        
Balance at beginning of period at Dec. 31, 2022 397,613 $ 766 665,941 188,241 (882) (456,453)
Increase (Decrease) in Stockholders' Equity [Roll Forward]            
Net income 125,541          
Foreign currency translation 1,066          
Unrealized loss on derivative instruments (3,188)          
Balance at end of period (in shares) at Jun. 30, 2023   47,065,370        
Balance at end of period at Jun. 30, 2023 481,024 $ 774 671,769 305,834 (3,004) (494,349)
Balance at beginning of period (in shares) at Mar. 31, 2023   47,626,067        
Balance at beginning of period at Mar. 31, 2023 424,443 $ 774 668,843 235,399 (554) (480,019)
Increase (Decrease) in Stockholders' Equity [Roll Forward]            
Net income 74,328     74,328    
Foreign currency translation 502       502  
Stock-based compensation (in shares)   24,550        
Stock-based compensation 2,915 2,915      
Stock repurchase (in shares)   (585,997)        
Stock repurchase (14,330)         (14,330)
Common stock dividends (3,893)     (3,893)    
Unrealized loss on derivative instruments (2,952)       (2,952)  
Stock option exercises (in shares)   750        
Stock option exercises 11   11      
Balance at end of period (in shares) at Jun. 30, 2023   47,065,370        
Balance at end of period at Jun. 30, 2023 481,024 $ 774 671,769 305,834 (3,004) (494,349)
Balance at beginning of period (in shares) at Dec. 31, 2023   45,393,260        
Balance at beginning of period at Dec. 31, 2023 549,496 $ 774 677,886 403,923 (428) (532,659)
Increase (Decrease) in Stockholders' Equity [Roll Forward]            
Net income 18,167     18,167    
Foreign currency translation 184       184  
Stock-based compensation (in shares)   334,955        
Stock-based compensation 3,246 $ 6 3,240      
Stock repurchase (in shares)   (589,144)        
Stock repurchase (22,138)         (22,138)
Common stock dividends (3,152)     (3,152)    
Unrealized loss on derivative instruments 276       276  
Stock option exercises (in shares)   500        
Stock option exercises 7   7      
Balance at end of period (in shares) at Mar. 31, 2024   45,139,571        
Balance at end of period at Mar. 31, 2024 546,086 $ 780 681,133 418,938 32 (554,797)
Balance at beginning of period (in shares) at Dec. 31, 2023   45,393,260        
Balance at beginning of period at Dec. 31, 2023 549,496 $ 774 677,886 403,923 (428) (532,659)
Increase (Decrease) in Stockholders' Equity [Roll Forward]            
Net income 47,125          
Foreign currency translation (1,008)          
Unrealized loss on derivative instruments (665)          
Balance at end of period (in shares) at Jun. 30, 2024   44,225,215        
Balance at end of period at Jun. 30, 2024 550,425 $ 781 684,504 443,734 (2,101) (576,493)
Balance at beginning of period (in shares) at Mar. 31, 2024   45,139,571        
Balance at beginning of period at Mar. 31, 2024 546,086 $ 780 681,133 418,938 32 (554,797)
Increase (Decrease) in Stockholders' Equity [Roll Forward]            
Net income 28,958     28,958    
Foreign currency translation (1,192)       (1,192)  
Stock-based compensation (in shares)   21,500        
Stock-based compensation 3,372 $ 1 3,371      
Stock repurchase (in shares)   (935,856)        
Stock repurchase (21,696)         (21,696)
Common stock dividends (4,162)     (4,162)    
Unrealized loss on derivative instruments (941)       (941)  
Stock option exercises (in shares)          
Stock option exercises 0        
Balance at end of period (in shares) at Jun. 30, 2024   44,225,215        
Balance at end of period at Jun. 30, 2024 $ 550,425 $ 781 $ 684,504 $ 443,734 $ (2,101) $ (576,493)